HOME >> BIOLOGY >> NEWS
Columbia University researchers create mouse model that develops a human-like lymphoma

Researchers at Columbia University Medical Center have created the first mouse model that develops a lymphoma the same way that humans do. This advancement has the potential to significantly speed the development of new, improved therapies for diffuse large B cell lymphoma (DLBCL), the most common type of human B cell lymphoma. Human B cell lymphomas cause 85 percent of non-Hodgkin's lymphomas, the sixth leading cause of cancer deaths in the United States.

The findings also confirm that a mutation in BCL6, the gene most frequently altered in this type of lymphoma, is the first step in its development, though other subsequent mutations also occur. In the study, mice with a mutant form of this gene spontaneously developed this lymphoma.

Cancer researchers have long been hindered by the lack of animal models to recreate both the genetics and biology of DLBCL. They had no way to test, with reliable accuracy, how an investigational therapy would work in humans with this disease. Also, this lack of animal models has slowed understanding of the BCL6 gene and its precise role in tumor development.

Published in the May 2005 issue of Cancer Cell, the study was led by Riccardo Dalla-Favera, M.D., one of the world's leading cancer geneticists and lymphoma researchers. Dr. Dalla-Favera is director of the Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center and NewYork-Presbyterian/Columbia. The HICCC is one of only three NIH-designated Comprehensive Cancer Centers in New York State. He is also director of the Institute for Cancer Genetics at Columbia University Medical center.

Dr. Dalla-Favera and his research team genetically engineered mice to produce a mutant BCL6 gene, showing the specific role of this gene in its pathogenesis and displaying most of the critical features of the corresponding human tumor. These findings expand on Dr. Dalla-Favera's identification of the BCL6 gene in 1994.

"We
'"/>

Contact: Elizabeth Streich
eas2125@columbia.edu
212-305-6535
Columbia University Medical Center
16-May-2005


Page: 1 2

Related biology news :

1. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
2. Columbia scientists determine 3-dimensional structure of cells fuel gauge
3. Columbia University licenses next-generation DNA sequencing technology
4. New bird discovered on unexplored Columbian mountain
5. Columbia University Medical Center receives major new NIH Clinical Science investment funds
6. Columbia University awards 2006 Horwitz Prize to biologist who explained gene transcription
7. Columbia University receives $16.9 million NIEHS award to study arsenic in ground water
8. Contaminants linked to sturgeon decline in Columbia river
9. Columbia University Medical Center researchers discover potential mechanism for tumor growth
10. UF, Columbia scientists closer to new cancer detection method
11. Columbia University awards 2005 Horwitz Prize to Israeli structural biologist

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/13/2018)... ... ... Illumina, Kaiser Permanente, ResMed and Aetna were just a few of the ... events company has hosted an impressive guest list of Fortune 500 businesses, namely due ... who visits receives a completely customized experience, right down to the menu and the ...
(Date:12/13/2018)... , ... December 13, 2018 , ... ... released a must-see documentary entitled “What Researchers Need to Know about Antibody ... in Life Science Research series. The goal of this film is to educate ...
(Date:12/10/2018)... ... December 10, 2018 , ... Today, RoosterBio ... their shared goal of accelerating the development of the Regenerative Medicine field. ... TRT’s core technology around human umbilical cord perivascular cells (HUCPVCs). Together, it ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... December 12, 2018 , ... Helping conclude Healthy Aging Month this past September, ... aid within its Vision and Hearing campaign that sets out to shed light on ... despite continued efforts to destigmatize hearing aids over the years, 9 out of 10 ...
(Date:12/10/2018)... SAN DIEGO (PRWEB) , ... ... ... Ltd., a fully integrated Contract Development and Manufacturing Organization (CDMO) with sites ... characterization, conjugation optimization, cGMP manufacturing, and aseptic fill finish solutions for monoclonal ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... The incredible ... paid tribute to in the European Parliament by Carlos Moedas, the European Commissioner for ... EU Research and Innovation in Our Daily Lives, Commissioner Moedas spoke at length of ...
(Date:12/5/2018)... CHARLOTTESVILLE, Va. and LONDON (PRWEB) , ... ... ... Atlantic Research Group (ARG), an established North American full-service contract research organization ... CRO. Effective immediately, the transaction significantly strengthens ARG’s reach and experience in ...
Breaking Biology Technology:
Cached News: